Purpose This study aims to investigate the prognostic value of pretreatment C-reactive
protein/albumin ratio (CAR) in human malignancies by an updated meta-analysis. Methods …

We aimed to review whether pretreatment inflammatory markers reflect the short-and long-
term outcomes of patients with colon cancer, rectal cancer, colon and rectal cancers, and …

Background: Emerging evidence suggests that inflammatory response biomarkers are
predictive factors that can improve the accuracy of colorectal cancer (CRC) prognoses. We …

Backgrounds The inflammatory biomarker “C-reactive protein to albumin ratio (CAR)” has
been reported to significantly correlate to a variety of human cancers. However, there are …

Background Frailty, represented by sarcopenia and osteopenia, has been associated with
worse survival after hepatectomy in patients with hepatocellular carcinoma. Recently, the …

Background In recent years, the role of pre-treatment C-reactive protein/albumin ratio (CAR)
in prognosis of esophageal cancer (EC) has been investigated by several studies. This meta …

Aim We investigated the prognostic impact of osteosarcopenia, which is the combination of
osteopenia and sarcopenia, in patients with colorectal liver metastases (CRLM) after hepatic …

Background Several kinds of systemic inflammatory response, classified into two types: C-
reactive protein (CRP)-based type and blood cell count-based type, were reported as a …

Background The preoperative systemic inflammation has been reported to predict tumor
recurrence and survival in various cancers, including colorectal liver metastases (CRLM) …

For resectable colorectal cancer (CRC), the standard treatment is perioperative adjuvant
treatment and complete resection. For unresectable CRC, the standard treatment is systemic …